US-based Lokavant, the clinical trial intelligence platform company, has announced an $8 million strategic investment fr...
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration ...
An examination of how clinical trials have changed in Australia over the past 15 years has identified challenges such as...
According to a February 2022 report by Research and Markets, the clinical trials market in India was estimated to be val...
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...
Singapore-based startup Hummingbird Bioscience has entered into a clinical trial collaboration and supply agreement with...
Jerome Armellini, Asia Head of Clinical Development & Operations Strategy and R&D Solutions (Asia), IQVIA, Asia ...
Omi Medical Center, a part of the Seikoukai Social Medical Corporation and one of Japan's leading institu...
In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian Contract ...
Australian biotech firm Vaxxas has announced the initiation of a Phase I clinical trial with the first inactivated ...
South Korean firm Wellmarker Bio (WMBIO) has entered a clinical trial collaboration and supply agreement with Merck (kno...
Australia's CardieX Limited, a global health technology company focused on patient-centric healthcare research and impro...
P3 Research, a leading New Zealand (NZ) clinical trials site network with seven locations across New Zealand, has t...
New Zealand's leading health agencies will explore system-level changes to improve benefits from clinical trials, based ...
Singapore-based startup Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun...
China-based startup Jacobio has entered into a clinical trial collaboration agreement with Merck on clinical study of co...
A multi-national, investigator-initiated and industry-backed clinical trial has been launched to test the efficacy of a ...
The Asia Pacific (APAC) region has taken in the lead in cell and gene clinical trials, accounting for the largest share ...
Australia-based Alterity Therapeutics has announced that the company’s Phase 2 clinical trial of ATH434 for ...
Hematogenix, the first central oncology laboratory for clinical trials in Malaysia has been officiated by the Minister o...
Crux Biolabs, a leading Australian laboratory for vaccines, immunotherapies, immuno-oncology and infectious diseases, ha...
Japan-based Aculys Pharma has entered into a contract with SUSMED, Inc., a company that promotes digital medicine, to co...
Singapore-based AUM Biosciences has entered into a clinical trial collaboration and supply agreement with Roche to evalu...
Genome and Company, a leading global microbiome anti-cancer drug development company in Korea, has entered into a first ...
